Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focal Cryotherapy for Intermediate Risk Prostate Cancer
NCT05454488Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2022
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Quality-of-life Questionnaires at 1 year and Negative in-field recurrence rate at 6 months. Started Jul 2022; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05454488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05454488.